Skip to product information
1 of 1

Paragon

KLOW 80MG (COMING SOON)

KLOW 80MG (COMING SOON)

Regular price $0.00 AUD
Regular price Sale price $0.00 AUD
Sale Sold out
Quantity

KLOW is a high-strength, multi-peptide research blend combining four compounds commonly studied across tissue repair, inflammatory signalling, cellular regeneration and recovery pathways.

Each vial contains:

BPC-157 10mg
A synthetic peptide primarily investigated for its potential role in soft-tissue repair, gastrointestinal integrity, angiogenesis and inflammatory regulation.

GHK-Cu 50mg
A naturally occurring copper-binding peptide researched for collagen production, skin regeneration, wound repair, antioxidant activity and overall tissue remodelling.

TB-500 10mg
A synthetic peptide associated with thymosin beta-4 research, particularly its involvement in cell migration, angiogenesis, flexibility and tissue-repair pathways.

KPV 10mg
A short melanocortin-derived peptide studied for its potential anti-inflammatory activity and effects on immune and gastrointestinal signalling.

By combining four complementary research compounds into one concentrated 80mg formulation, KLOW offers a comprehensive platform for studying multiple aspects of inflammation, cellular repair and tissue regeneration within a single blend.

Total blend: 80mg

  • BPC-157: 10mg
  • GHK-Cu: 50mg
  • TB-500: 10mg
  • KPV: 10mg

Product Information

  • Compound: KLOW
  • Form: Lyophilised powder
  • Purity: Independently tested (COA available)
  • Handling: Reconstitution and storage should follow standard laboratory protocols

Quality & Testing

All Paragon compounds undergo third-party analytical testing to verify purity, identity, and consistency. Certificates of Analysis (COAs) are available for transparency and quality assurance.

Important Notice

This compound is sold exclusively for research purposes.
Not approved for human consumption, injection, or therapeutic use.
Purchasers must be 18 years or older and acknowledge responsibility for proper laboratory handling.

View full details